Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Statistical Software for Data Analysis and Clinical Trials01:12

Statistical Software for Data Analysis and Clinical Trials

526
Statistical software is pivotal in data analysis and clinical trials by providing tools to analyze data, draw conclusions, and make predictions. These software packages range from simple data management applications to complex analytical platforms, supporting various statistical tests, models, and simulation techniques. Their significance lies in their ability to handle vast amounts of data with precision and efficiency, enabling researchers to validate hypotheses, identify trends, and make...
526
Longitudinal Research02:20

Longitudinal Research

11.9K
Sometimes we want to see how people change over time, as in studies of human development and lifespan. When we test the same group of individuals repeatedly over an extended period of time, we are conducting longitudinal research. Longitudinal research is a research design in which data-gathering is administered repeatedly over an extended period of time. For example, we may survey a group of individuals about their dietary habits at age 20, retest them a decade later at age 30, and then again...
11.9K
Clinical Trials01:16

Clinical Trials

6.6K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
6.6K
Introduction to Epidemiology01:26

Introduction to Epidemiology

682
Epidemiology, known as the cornerstone of public health, involves studying the distribution and determinants of health-related events in defined populations and applying these insights to control health issues. This is essential for understanding how diseases spread, identifying populations at greater risk, and implementing measures to control or prevent outbreaks. Epidemiology addresses not only infectious diseases but also non-communicable conditions like cancer and cardiovascular disease,...
682

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A novel analysis methodology for assessment of re-identification risks for the National Cancer Institute cancer registry privacy preserving record linkage technique.

Journal of the American Medical Informatics Association : JAMIA·2025
Same author

Large-scale deep learning for metastasis detection in pathology reports.

JAMIA open·2025
Same author

Enrollment in Children's Oncology Group's clinical trials: population-based linkage with the National Childhood Cancer Registry.

Journal of the National Cancer Institute·2025
Same author

Coronavirus Disease 2019 (COVID-19) Real World Data Infrastructure: A Big-Data Resource for Study of the Impact of COVID-19 in Patient Populations With Immunocompromising Conditions.

Open forum infectious diseases·2025
Same author

Making the case for an International Childhood Cancer Data Partnership.

Journal of the National Cancer Institute·2025
Same author

Development of message passing-based graph convolutional networks for classifying cancer pathology reports.

BMC medical informatics and decision making·2024

Related Experiment Video

Updated: Jun 17, 2025

Procedure for Adaptive Laboratory Evolution of Microorganisms Using a Chemostat
06:03

Procedure for Adaptive Laboratory Evolution of Microorganisms Using a Chemostat

Published on: September 20, 2016

14.4K

The SEER Program's evolution: supporting clinically meaningful population-level research.

Lynne Penberthy1, Steven Friedman1

  • 1Surveillance Research Program, Division of Cancer Control and Population Sciences, National Cancer Institute, Bethesda, MD, USA.

Journal of the National Cancer Institute. Monographs
|August 5, 2024
PubMed
Summary
This summary is machine-generated.

The Surveillance, Epidemiology, and End Results (SEER) Program is enhancing data collection beyond initial diagnosis to include molecular tumor characteristics and comprehensive treatment histories. This expansion is crucial for understanding patient outcomes in precision oncology.

More Related Videos

Heuristic Mining of Hierarchical Genotypes and Accessory Genome Loci in Bacterial Populations
08:03

Heuristic Mining of Hierarchical Genotypes and Accessory Genome Loci in Bacterial Populations

Published on: December 7, 2021

2.1K
Following the Dynamics of Structural Variants in Experimentally Evolved Populations
04:52

Following the Dynamics of Structural Variants in Experimentally Evolved Populations

Published on: February 3, 2023

939

Related Experiment Videos

Last Updated: Jun 17, 2025

Procedure for Adaptive Laboratory Evolution of Microorganisms Using a Chemostat
06:03

Procedure for Adaptive Laboratory Evolution of Microorganisms Using a Chemostat

Published on: September 20, 2016

14.4K
Heuristic Mining of Hierarchical Genotypes and Accessory Genome Loci in Bacterial Populations
08:03

Heuristic Mining of Hierarchical Genotypes and Accessory Genome Loci in Bacterial Populations

Published on: December 7, 2021

2.1K
Following the Dynamics of Structural Variants in Experimentally Evolved Populations
04:52

Following the Dynamics of Structural Variants in Experimentally Evolved Populations

Published on: February 3, 2023

939

Area of Science:

  • Cancer surveillance and epidemiology
  • Precision oncology and outcomes research

Background:

  • Traditional cancer registries like the Surveillance, Epidemiology, and End Results (SEER) Program collected limited data, primarily at diagnosis.
  • These traditional methods are insufficient for understanding varied patient outcomes, especially with advancements in precision oncology.
  • Molecular tumor characteristics and comprehensive treatment data are vital for explaining outcome disparities among similar patients.

Purpose of the Study:

  • To introduce key enhancements to the SEER Program's data collection processes.
  • To establish a foundation for a JNCI Monograph detailing innovative methods in cancer surveillance.
  • To highlight the need for evaluating and evolving SEER data to meet modern oncology research demands.

Main Methods:

  • Expansion of the SEER Program's population coverage.
  • Enhancement of data types collected, moving beyond initial diagnosis information.
  • Incorporation of molecular tumor characteristics (e.g., BRCA status) and comprehensive longitudinal treatment data.

Main Results:

  • The SEER Program is actively implementing new data collection strategies.
  • These enhancements aim to capture critical risk factors influencing patient outcomes.
  • Focus is placed on collecting data on subsequent therapies for recurrent or progressive disease.

Conclusions:

  • Enhanced SEER data are essential for understanding cancer outcomes in the era of precision medicine.
  • Capturing molecular and comprehensive treatment data will improve risk stratification and patient decision-making.
  • These improvements are critical for advancing cancer research and improving patient care.